Newest first. 5.2k questions across 107 tags.
Details up front: a GLP-1 receptor agonist · 15 mg. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out,…
Details up front: 96.4% · Janoshik · 95.2% · Medutest. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
Details up front: KP · orforglipron. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
What I am working with: SURMOUNT-OSA · nausea. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Conditions: 96.8% · a C4 column · retatrutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Conditions: ecnoglutide · twelve weeks · minus 80 °C. This is one of those things that everyone repeats and nobody derives. This matters practically, not just…
Concretely: 96.4% · oral semaglutide · BCH. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write…
The specifics, since they change the answer: STEP 5 · early satiety. I have the document in front of me and I can read the numbers. What I cannot do is interpret…
Conditions: GGPeps · TFC · Spain. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising for price, but I…
Conditions: fatigue · three · mazdutide. I have read the obvious sources and they disagree with each other, so I would rather ask people who have actually done this.…
For reference: SURPASS-3 · early satiety · 15 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
The particulars: 97.1% · PeptideMeter · 99.4% · Medutest. I am trying to choose between two options that are usually discussed as though only one exists. I am not…
What I am working with: SOUL · reflux · 14 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Setup, so nobody has to ask: 97.6% · a GLP-1 receptor agonist · HJ. I am trying to build something sustainable rather than something thorough that I will abandon. I…
Stated plainly: dimerisation · cagrilintide · minus 20 °C. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I…
Numbers first: PIONEER-4 · hair thinning · 25 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Setup, so nobody has to ask: SGN · Shanghai · Germany. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the…
Details up front: WWB · a quantified content assay. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary;…
Concretely: eGFR · dulaglutide. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how confident the…
Numbers first: 98.4% · a C8 column · tirzepatide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
What I have: mazdutide · Wuhan. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable version,…
For reference: SWB · Xianning · Japan. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I can predict the outcome but I cannot explain it, which means I will get…
Conditions: 97.6% · date of analysis. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…